|本期目录/Table of Contents|

[1]谢永丽,汤华.YTHDF1对HBV蛋白表达和HBsAg和HBeAg抗原分泌的作用[J].天津医科大学学报,2021,27(05):461-466.
　XIE Yong-li,TANG Hua.Role of YTHDF1 on HBV protein expression and secretion of HBsAg and HBeAg antigens[J].Journal of Tianjin Medical University,2021,27(05):461-466.
点击复制

YTHDF1对HBV蛋白表达和HBsAg和HBeAg抗原分泌的作用(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年05期
页码:
461-466
栏目:
基础医学
出版日期:
2021-09-10

文章信息/Info

Title:
Role of YTHDF1 on HBV protein expression and secretion of HBsAg and HBeAg antigens
文章编号:
1006-8147(2021)05-0538-03
作者:
谢永丽; 汤华
（天津医科大学基础医学院病原生物学系，天津300070）
Author(s):
XIE Yong-li;  TANG Hua
（Department of Pathogenic Biology，School of Basic Medical Sciences，Tianjin Medical University，Tianjin 300070，China）
关键词:
肝癌; 乙型肝炎病毒; YTH N6-甲基腺苷RNA结合蛋白1; 乙型肝炎病毒表面抗原; 乙型肝炎病毒e抗原
Keywords:
HCC;  HBV;  YTHDF1;  HBsAg;  HBeAg
分类号:
R373.2+1
DOI:
-
文献标志码:
A
摘要:
目的：探讨YTH N6-甲基腺苷RNA结合蛋白1（YTHDF1）对乙型肝炎病毒（HBV）蛋白表达和抗原分泌的影响。方法：分别以pCD3/Flag-KBE和pSilencer2.1-U6 neo为载体，构建过表达和敲降YTHDF1质粒。在Huh7细胞中过表达HBV蛋白质粒的同时表达pshR-YTHDF1和对照质粒，通过Western印迹检测YTHDF1对HBV蛋白表达的影响。在HepG2.2.15细胞中过表达和敲降YTHDF1, 在Huh7细胞中同时过表达pHBV1.3质粒，通过ELISA检测YTHDF1对HBsAg、HBeAg抗原分泌的影响。结果：与正常肝细胞相比，YTHDF1在肝癌细胞Huh7（t=17.4）、HepG2.2.15细胞中（t=39.6）高表达。成功构建过表达和敲降YTHDF1质粒并验证其有效。敲降YTHDF1抑制HBV基因组编码的HBc蛋白（t=9.5）、HBs蛋白（t=5.2）、preS1蛋白（t=25.7）、preS2蛋白（t=9.0）、HBx蛋白（t=19.7）、HBV DNA Pol蛋白（t=23.0）表达，差异均有统计学意义（均P＜0.05）。过表达YTHDF1促进HBsAg（Huh7细胞t48 h=5.5，t72 h=5.0；HepG2.2.15细胞 t48 h=5.3，t72 h=27.4）、HBeAg抗原（Huh7细胞t48 h=5.7，t72 h=6.3；HepG2.2.15细胞t48 h=29.0，t72 h=6.6）的分泌，而敲降YTHDF1抑制HBsAg（Huh7细胞t48 h=16.0，t72 h=7.9；HepG2.2.15细胞t48 h=22.3，t72 h=7.0）、HBeAg抗原（Huh7细胞t48 h=9.0，t72 h=14.3；HepG2.2.15细胞t48 h=8.1，t72 h=6.6）的分泌（均P＜0.05）。结论：YTHDF1可能具有增加HBV蛋白表达及促进HBsAg和HBeAg抗原分泌的作用。
Abstract:
Objective: To investigate the effect of YTH N6-methyladenosine RNA-binding protein 1（YTHDF1） on hepatitis B virus （HBV） protein expression and antigen secretion. Methods: Overexpression and knockdown YTHDF1 plasmids were constructed using pCD3/Flag-KBE and pSilencer2.1-U6 neo as vectors，respectively. HBV protein plasmid was overexpressed in Huh7 cells along with pshR-YTHDF1 and control plasmid，and the effect of YTHDF1 on HBV protein expression was examined by Western blotting assay. YTHDF1 was overexpressed and knocked down in HepG2.2.15 cells，simultaneous pHBV1.3 plasmid was overexpressed in Huh7 cells，and the effect of YTHDF1 on HBsAg and HBeAg antigen secretion were detected by ELISA. Results: YTHDF1 was highly expressed in hepatocellular carcinoma cells Huh7（t=17.4），HepG2.2.15 cells（t=39.6） compared to normal hepatocytes. Overexpression and knockdown YTHDF1 plasmids were successfully constructed and verified to be effective. Knockdown of YTHDF1 inhibited the expression of HBc protein（t=9.5），HBs protein（t=5.2），preS1 protein（t=25.7），preS2 protein（t=9.0），HBx protein（t=19.7），and HBV DNA Pol protein（t=23.0） encoded by HBV genome，and the differences were statistically significant（all P<0.05）. Over expression of YTHDF1 promoted the secretion of HBsAg （Huh7 cells t48 h=5.5，t72 h=5.0；HepG2.2.15 cells t48 h=5.3，t72 h=27.4），HBeAg antigen（Huh7 cells t48 h=5.7，t72 h=6.3； HepG2.2.15 cells t48 h=29.0，t72 h=6.6） and knockdown of YTHDF1 inhibited the secretion of HBsAg（Huh7 cells t48 h=16.0，t72 h=7.9，HepG2.2.15 cells t48 h=22.3，t72 h =7.0），HBeAg antigen（Huh7 cells t48 h=9.0，t72 h=14.3，HepG2.2.15 cells t48 h=8.1，t72 h=6.6），all P<0.05. Conclusion: YTHDF1 may have a role in increasing HBV protein expression and promoting the secretion of HBsAg and HBeAg antigens.

参考文献/References:

[1] LIU T，WEI Q，JIN J，et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation[J]. Nucleic Acids Res，2020，48（7）：3816
[2] SHI H，ZHANG X，WENG Y L，et al. m（6）A facilitates hippocampus-dependent learning and memory through YTHDF1[J]. Nature，2018， 563（7730）：249
[3] LIAW Y F，SUNG J J，CHOW W C，et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease[J]. N Engl J Med，2004，351（15）：1521
[4] KUBO S，TANAKA H，TAKEMURA S，et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus[J]. Hepatol Res，2007，37（2）：94
[5] HOSAKA T，SUZUKI F，KOBAYASHI M，et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection[J]. Hepatology，2013，58（1）：98
[6] KIM W R，LOOMBA R，BERG T，et al. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B[J]. Cancer，2015，121（20）：3631
[7] DARGAN A，WONG S Y，COBEN R，et al. Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression[J]. Minerva Gastroenterol Dietol，2017，63（1）：74
[8] YUE Y，LIU J，HE C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation[J]. Genes Dev，2015，29（13）：1343
[9] ZHOU J，WAN J，GAO X，et al. Dynamic m（6）A mRNA methylation directs translational control of heat shock response[J]. Nature，2015， 526（7574）：591
[10] WANG X，LU Z，GOMEZ A，et al. N6-methyladenosine-dependent regulation of messenger RNA stability[J]. Nature，2014，505（7481）：117
[11] ZHANG Y Y，HU K Q. Rethinking the pathogenesis of hepatitis B virus （HBV） infection[J]. J Med Virol，2015，87（12）：1989
[12] MA J Z，YANG F，ZHOU C C，et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N（6） -methyladenosine-dependent primary microRNA processing[J]. Hepatology，2017，65（2）：529
[13] ZHONG L，LIAO D，ZHANG M，et al. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma[J]. Cancer Lett，2019，442：252
[14] CHENG X，LI M，RAO X，et al. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA[J]. Onco Targets Ther，2019，12：3421
[15] CHEN M，WEI L，LAW C T，et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2[J]. Hepatology，2018，67（6）：2254
[16] ZHOU Y，YIN Z，HOU B，et al. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma：evidence from independent datasets[J]. Cancer Manag Res，2019，11：3921
[17] TANABE A，KONNO J，TANIKAWA K，et al. Transcriptional machinery of TNF-alpha-inducible YTH domain containing 2（YTHDC2） gene[J]. Gene，2014，535（1）：24
[18] IMAM H，KHAN M，GOKHALE N S，et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle[J]. Proc Natl Acad Sci USA，2018，115（35）：8829-8834.

相似文献/References:

[1]陈 环.肝癌介入治疗前后α2-抗纤溶酶、抗凝血酶Ⅲ、凝血因子Ⅷ检测的临床意义[J].天津医科大学学报,2014,20(04):327.
[2]申晓敏,王春妍,程晓静.FibroTest与肝纤维化4项指标评价慢性乙型肝炎纤维化的研究[J].天津医科大学学报,2015,21(06):507.
　SHEN Xiao-min,WANG Chun-yan,CHENG Xiao-jing.Diagnostic value of FibroTest combined with four serum liver fibrosis biomarkers for liver fibrosis in patients with chronic hepatitis B[J].Journal of Tianjin Medical University,2015,21(05):507.
[3]程婷婷,王凤梅,朱争艳,等.HBV慢性感染者肝脏组织中CD4+T、CD8+T和FoxP3+Tregs细胞的表达水平[J].天津医科大学学报,2016,22(02):129.
　CHENG Ting-ting,WANG Feng-mei,ZHU Zheng-yan,et al.Level of CD4+T、CD8+T and FoxP3+Tregs in the liver tissues of patients with chronic HBV infection[J].Journal of Tianjin Medical University,2016,22(05):129.
[4]杨 柳,王绕绕,尹明丽,等.自体特异性免疫效应淋巴细胞抑制转HBV基因小鼠HBV复制的研究[J].天津医科大学学报,2017,23(01):11.
　YANG Liu,WANG Rao-rao,YIN Ming-li,et al.Study on effect of autologous specific immune effective cells on inhibiting HBV replication in HBV transgenic mice[J].Journal of Tianjin Medical University,2017,23(05):11.
[5]廖诗晗,赵秀兰,张艳辉,等.LCMT1在肝癌中的表达和预后的意义[J].天津医科大学学报,2019,25(03):246.
　LIAO Shi-han,ZHAO Xiu-lan,ZHANG Yan-hui,et al.The expression and prognostic significance of LCMT1 in hepatocellular carcinoma[J].Journal of Tianjin Medical University,2019,25(05):246.
[6]张丽梅,贾莉莉 综 述,喻文立 审 校.外泌体在病毒性肝炎、肝硬化和肝癌中的作用研究进展[J].天津医科大学学报,2019,25(03):305.
[7]陈莹,张雅敏.围手术期肠内、外营养治疗在肝切除术后患者快速康复中的作用[J].天津医科大学学报,2021,27(04):384.
　CHEN Ying,ZHANG Ya-min.Effect of perioperative enteral and parenteral nutrition on rapid recovery of patients after hepatectomy[J].Journal of Tianjin Medical University,2021,27(05):384.
[8]张荣芳,钱磊,常明杰,等.血清HBV RNA在慢性乙型肝炎抗病毒治疗过程中的动态变化及其临床意义[J].天津医科大学学报,2021,27(05):520.
　ZHANG Rong-fang,QIAN Lei,CHANG Ming-jie,et al.Dynamic changes and clinical significance of serum HBV RNA in patients with chronic hepatitis B during antiviral therapy[J].Journal of Tianjin Medical University,2021,27(05):520.
[9]赵冉,武燕洁,刘振凤,等.基于TCGA数据库分析JMJD6在肝癌组织中的表达及临床意义[J].天津医科大学学报,2022,28(01):15.
　ZHAO Ran,WU Yan-jie,LIU Zhen-feng,et al.The expression and clinical significance of JMJD6 in hepatocellular carcinoma based on TCGA database[J].Journal of Tianjin Medical University,2022,28(05):15.
[10]武燕洁,李譞媛,宣成昊,等.利用TCGA数据库分析MED19基因在肝癌中的表达及临床意义[J].天津医科大学学报,2022,28(04):383.
　WU Yan-jie,LI Xuan-yuan,XUAN Cheng-hao,et al.Analyze the expression and clinical significance of MED19 gene in hepatocellular carcinoma based on TCGA database[J].Journal of Tianjin Medical University,2022,28(05):383.
[11]胡善雷,李广明,任 娜,等.GP73在HBV相关性肝病中的水平及意义[J].天津医科大学学报,2019,25(06):615.
　HU Shan-lei,LI Guang-ming,REN Na,et al.The level and significance of GP73 in HBV related liver diseases[J].Journal of Tianjin Medical University,2019,25(05):615.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金重点项目（81830094）
作者简介 谢永丽（1994-），女，硕士在读，研究方向：病原生物学；通信作者：汤华，E-mail：htang2002@yahoo.com。
更新日期/Last Update: 2021-09-01